Sanofi's focus on patients has driven our historical and ongoing strategy to create long-term value by researching and delivering innovative treatments.
Sanofi Oncology's heritage in oncology has given us an extensive knowledgebase that enriches our current research expertise. This experience encompasses
a wide variety of cancer types, disease stages, patient populations, and patient needs. As a global healthcare company focused on patient needs, we are
committed to attacking cancer on many fronts.
Today, our pipeline spans multiple therapeutic areas within oncology, across both solid tumors, hematology and transplant.
We are an industry leader in the development of cytotoxic agents, which remain the foundation of cancer treatment. In addition to traditional chemotherapy,
we are also investigating targeted agents and novel approaches, such as gene-focused therapy and drug-antibody combinations that may play an important role
in advancing cancer management in the future.
While research into new therapeutic approaches is of vital importance, we cannot forget that cancer research is about people who are fighting for their lives.
For this reason, our innovative patient awareness and support programs continue to expand. Through our collaborations, we strive to transform scientific
innovation into hope and solutions for patients.
Learn more about our approach to improving patient outcomes through our Leadership and Partnership.